These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28463790)

  • 1. Dexmedetomidine inhibits activation of the MAPK pathway and protects PC12 and NG108-15 cells from lidocaine-induced cytotoxicity at its maximum safe dose.
    Wang Q; Tan Y; Zhang N; Xu Y; Wei W; She Y; Bi X; Zhao B; Ruan X
    Biomed Pharmacother; 2017 Jul; 91():162-166. PubMed ID: 28463790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexmedetomidine protects PC12 cells from lidocaine-induced cytotoxicity via downregulation of Stathmin 1.
    Tan Y; Bi X; Wang Q; Li Y; Zhang N; Lao J; Liu X
    Drug Des Devel Ther; 2019; 13():2067-2079. PubMed ID: 31308624
    [No Abstract]   [Full Text] [Related]  

  • 3. Dexmedetomidine protects against lidocaine-induced neurotoxicity through SIRT1 downregulation-mediated activation of FOXO3a.
    Zheng LN; Guo FQ; Li ZS; Wang Z; Ma JH; Wang T; Wei JF; Zhang WW
    Hum Exp Toxicol; 2020 Sep; 39(9):1213-1223. PubMed ID: 32228195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexmedetomidine Protects PC12 Cells from Lidocaine-Induced Cytotoxicity Through Downregulation of COL3A1 Mediated by miR-let-7b.
    Wang Q; She Y; Bi X; Zhao B; Ruan X; Tan Y
    DNA Cell Biol; 2017 Jul; 36(7):518-528. PubMed ID: 28436683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexmedetomidine Protects Against Chemical Hypoxia-Induced Neurotoxicity in Differentiated PC12 Cells Via Inhibition of NADPH Oxidase 2-Mediated Oxidative Stress.
    Chen XH; Chen DT; Huang XM; Chen YH; Pan JH; Zheng XC; Zeng WA
    Neurotox Res; 2019 Jan; 35(1):139-149. PubMed ID: 30112693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of dexmedetomidine on neuronal hypoxic injury through inhibition of miR-134.
    Li YJ; Zhang DZ; Xi Y; Wu CA
    Hum Exp Toxicol; 2021 Dec; 40(12):2145-2155. PubMed ID: 34121490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexmedetomidine Reduces the Lidocaine-Induced Neurotoxicity by Inhibiting Inflammasome Activation and Reducing Pyroptosis in Rats.
    Ding XD; Cao YY; Li L; Zhao GY
    Biol Pharm Bull; 2021; 44(7):902-909. PubMed ID: 34193687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine Attenuates Glutamate-Induced Cytotoxicity by Inhibiting the Mitochondrial-Mediated Apoptotic Pathway.
    Zhang W; Yu J; Guo M; Ren B; Tian Y; Hu Q; Xie Q; Xu C; Feng Z
    Med Sci Monit; 2020 May; 26():e922139. PubMed ID: 32419697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexmedetomidine Alleviates Lipopolysaccharide-Induced Hippocampal Neuronal Apoptosis via Inhibiting the p38 MAPK/c-Myc/CLIC4 Signaling Pathway in Rats.
    Chen Y; Li L; Zhang J; Cui H; Wang J; Wang C; Shi M; Fan H
    Mol Neurobiol; 2021 Nov; 58(11):5533-5547. PubMed ID: 34363182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexmedetomidine mitigates lidocaine-induced spinal cord injury by repressing ferritinophagy-mediated ferroptosis by increasing CISD2 expression in rat models.
    Tan Y; Wang Q; Guo Y; Zhang N; Xu Y; Bai X; Liu J; Bi X
    J Bioenerg Biomembr; 2024 Oct; 56(5):517-530. PubMed ID: 39168950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexmedetomidine attenuates acute lung injury induced by lipopolysaccharide in mouse through inhibition of MAPK pathway.
    Xu Y; Zhang R; Li C; Yin X; Lv C; Wang Y; Zhao W; Zhang X
    Fundam Clin Pharmacol; 2015 Oct; 29(5):462-71. PubMed ID: 26211495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexmedetomidine exerts neuroprotective effects during high glucose-induced neural injury by inhibiting miR-125b.
    Hou X; Xu F; Zhang C; Shuai J; Huang Z; Liang Y; Xu X
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32538430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both PI3K/Akt and ERK1/2 pathways participate in the protection by dexmedetomidine against transient focal cerebral ischemia/reperfusion injury in rats.
    Zhu YM; Wang CC; Chen L; Qian LB; Ma LL; Yu J; Zhu MH; Wen CY; Yu LN; Yan M
    Brain Res; 2013 Feb; 1494():1-8. PubMed ID: 23219579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of miRNA-151-3p enhanced the neuroprotective effect of dexmedetomidine against β-amyloid by targeting DAPK-1 and TP53.
    Guo Y; Wu Y; Li N; Wang Z
    Exp Mol Pathol; 2021 Feb; 118():104587. PubMed ID: 33275947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective role of Bcl-2 on beta-amyloid-induced cell death of differentiated PC12 cells: reduction of NF-kappaB and p38 MAP kinase activation.
    Song YS; Park HJ; Kim SY; Lee SH; Yoo HS; Lee HS; Lee MK; Oh KW; Kang SK; Lee SE; Hong JT
    Neurosci Res; 2004 May; 49(1):69-80. PubMed ID: 15099705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both JNK and P38 MAPK pathways participate in the protection by dexmedetomidine against isoflurane-induced neuroapoptosis in the hippocampus of neonatal rats.
    Liao Z; Cao D; Han X; Liu C; Peng J; Zuo Z; Wang F; Li Y
    Brain Res Bull; 2014 Aug; 107():69-78. PubMed ID: 25026397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexmedetomidine (12.5 μg/mL) improves tissue distribution, anesthetic action, and hemodynamic effects of lidocaine after palatal infiltration in rats.
    Akimoto T; Hashimoto S; Sunada K
    Odontology; 2016 Sep; 104(3):390-6. PubMed ID: 26695161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotoxicity of sub-anesthetic doses of sevoflurane and dexmedetomidine co-administration in neonatal rats.
    Perez-Zoghbi JF; Zhu W; Neudecker V; Grafe MR; Brambrink AM
    Neurotoxicology; 2020 Jul; 79():75-83. PubMed ID: 32387222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexmedetomidine dose-dependently enhances local anesthetic action of lidocaine.
    Ouchi K; Koga Y; Nakao S; Sugiyama K
    J Oral Maxillofac Surg; 2014 Mar; 72(3):474-80. PubMed ID: 24268964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexmedetomidine Protects Neural Stem Cells from Ketamine-Induced Injury.
    Lu P; Lei S; Li W; Lu Y; Zheng J; Wang N; Xia Y; Lu H; Chen X; Liu Y; Zhang PB
    Cell Physiol Biochem; 2018; 47(4):1377-1388. PubMed ID: 29929189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.